N-苄基-4-溴苯磺酰胺 | 3609-87-8

• 物质功能分类: 原料药 - 人工合成抗感染类药 - 磺胺类药及增效剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-苄基-4-溴苯磺酰胺
• 英文名称: N-benzyl-4-bromobenzenesulfonamide
• CAS: 3609-87-8
• 化学式: C₁₃H₁₂BrNO₂S
• mdl: MFCD00450587
• 分子量: 326.214
• InChiKey: KBFYMIDQZWIKJR-UHFFFAOYSA-N

物化性质

• 熔点：
  102-104

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2935009090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存储条件：2-8°C，干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
N-Benzyl 4-bromobenzenesulfonamide
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
N-Benzyl 4-bromobenzenesulfonamide
Ingredient name:
CAS number: 3609-87-8

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C13H12BrNO2S
Molecular weight: 326.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-苄基-4-溴苯磺酰胺 在 N-羟基邻苯二甲酰亚胺 、 碘苯二乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 以83%的产率得到4-bromo-N-benzylidenebenzenesulfonamide
  参考文献：
  名称：

  实际 N-羟基邻苯二甲酰亚胺介导的磺酰胺氧化成 N-磺酰亚胺

  摘要：

  开发了一种在温和条件下通过 N-羟基邻苯二甲酰亚胺介导的磺酰胺氧化制备磺酰亚胺的新方法。与报道的氧化方法相比，我们的方法实现了更广泛的底物范围和更温和的条件。重要的是，这种氧化方法可以使用曼尼希产物作为起始原料提供 N-磺酰基烯胺酮。此外，在我们的系统中形成的未分离的 N-磺酰亚胺与 1,3,5-三甲氧基苯的一锅 Friedel-Crafts 芳基化反应在没有任何额外催化剂的情况下是成功的。

  DOI：

  10.3390/molecules24203771
• 作为产物：
  描述：

  4-溴苯磺酰胺 在 四氢吡咯 、 甲醇 、 potassium tert-butylate 、 联硼酸频那醇酯 、 copper(l) chloride 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 12.0h， 生成 N-苄基-4-溴苯磺酰胺
  参考文献：
  名称：

  Copper-boryl mediated transfer hydrogenation of N-sulfonyl imines using methanol as the hydrogen donor

  摘要：

  DOI：

  10.1016/j.tet.2021.132063

文献信息

• [EN] TRIAZOLONE COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS DE TRIAZOLONE ET LEURS UTILISATIONS
  申请人：INCEPTION 2 INC

  公开号：WO2013134562A1

  公开（公告）日：2013-09-12

  The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections. The invention disclosed herein is also directed to a methods of preventing the onset of and/or recurrence of acute and chronic myeloid leukemia, as well as other cancers, comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist.

  本发明涉及的化合物属于式(I)及其药学上可接受的盐，可用于治疗前列腺、乳腺、结肠、胰腺、人类慢性淋巴细胞白血病、黑色素瘤和其他癌症。该发明还包括含有式(I)化合物的治疗有效量或其药学上可接受的盐的药物组合物。本发明还涉及治疗前列腺、乳腺、卵巢、肝脏、肾脏、结肠、胰腺、人类慢性淋巴细胞白血病、黑色素瘤和其他癌症的方法。本发明还涉及治疗前列腺、乳腺、结肠、胰腺、慢性淋巴细胞白血病、黑色素瘤和其他癌症的方法，包括给予选择性PPARα拮抗剂的治疗有效量。本发明的化合物和药物组合物还可用于治疗病毒感染，如HCV感染和HIV感染。本发明还涉及一种预防急性和慢性骨髓性白血病以及其他癌症发作和/或复发的方法，包括给予选择性PPARα拮抗剂的治疗有效量。
• Gold-Catalyzed <i>syn</i>-1,2-Difunctionalization of Ynamides via Nitrile Activation
  作者：Rajeshwer Vanjari、Shubham Dutta、Manash P. Gogoi、Vincent Gandon、Akhila K. Sahoo

  DOI：10.1021/acs.orglett.8b03830

  日期：2018.12.21

  Developed is an unprecedented Au(I)-catalyzed syn-1,2-difunctionalization of ynamides with 2-aminobenzonitriles via nitrile activation. The coupling between ynamides and 2-aminobenzonitriles is explicitly regioselective, providing a straightforward access to 2,4-diamino-substituted quinolines. Density functional theory (DFT) study provides insightful information and rationalizes the reaction pathway

  通过腈活化，开发了前所未有的Au（I）催化的2-（2-氨基苄腈）酰胺类的Au（I）催化syn -1,2-双官能化。乙酰胺和2-氨基苄腈之间的偶联具有明确的区域选择性，可直接获得2,4-二氨基取代的喹啉。密度泛函理论（DFT）研究提供了有见地的信息并合理化了反应途径。它显示了Au（I）催化剂在酰胺π活化和腈σ配位之间的协同作用如何使环化可行。
• Manganese-Catalyzed <i>N</i>-Alkylation of Sulfonamides Using Alcohols
  作者：Benjamin G. Reed-Berendt、Louis C. Morrill

  DOI：10.1021/acs.joc.9b00203

  日期：2019.3.15

  An efficient manganese-catalyzed N-alkylation of sulfonamides has been developed. This borrowing hydrogen approach employs a well-defined and bench-stable Mn(I) PNP pincer precatalyst, allowing benzylic and simple primary aliphatic alcohols to be employed as alkylating agents. A diverse range of aryl and alkyl sulfonamides undergoes mono-N-alkylation in excellent isolated yields (32 examples, 85% average

  已经开发了有效的锰催化的磺酰胺的N-烷基化。这种借用氢的方法使用了定义明确且稳定的Mn（I）PNP夹钳式预催化剂，从而允许将苄基和简单的伯脂肪族醇用作烷基化剂。各种范围的芳基和烷基磺酰胺均以优异的分离收率进行单N烷基化（32个实例，平均收率85％）。
• Cobalt‐Catalyzed 1,4‐Aryl Migration/Desulfonylation Cascade: Synthesis of α‐Aryl Amides
  作者：Nicolas Gillaizeau‐Simonian、Etienne Barde、Amandine Guérinot、Janine Cossy

  DOI：10.1002/chem.202005129

  日期：2021.2.24

  A cobalt‐catalyzed 1,4‐aryl migration/disulfonylation cascade applied to α‐bromo N‐sulfonyl amides was developed. The reaction was highly chemoselective, allowing the preparation of α‐aryl amides possessing a variety of functional groups. The method was used as the key step to synthesize an alkaloid, (±)‐deoxyeseroline. Mechanistic investigations suggest a radical process.

  开发了应用于α-溴代N-磺酰基酰胺的钴催化的1,4-芳基迁移/二磺酰化级联反应。该反应具有高度的化学选择性，可以制备具有各种官能团的α-芳基酰胺。该方法被用作合成生物碱（±）-脱氧羟脯氨酸的关键步骤。机械研究表明这是一个激进的过程。
• A segmented flow platform for on-demand medicinal chemistry and compound synthesis in oscillating droplets
  作者：Ye-Jin Hwang、Connor W. Coley、Milad Abolhasani、Andreas L. Marzinzik、Guido Koch、Carsten Spanka、Hansjoerg Lehmann、Klavs F. Jensen

  DOI：10.1039/c7cc03584e

  日期：——

  We report an automated flow chemistry platform that can efficiently perform a wide range of chemistries, including single/multi-phase and single/multi-step, with a reaction volume of just 14 μL. The breadth of compatible chemistries is successfully demonstrated and the desired products are characterized, isolated, and collected online by preparative HPLC/MS/ELSD.

  我们报告了一个自动化的流动化学平台，该平台可以有效地执行各种化学反应，包括单相/多相和单步/多步，反应体积仅为14μL。通过制备型HPLC / MS / ELSD成功地证明了兼容化学的广度，并在线表征，分离和收集了所需的产品。

表征谱图